Clinical trial
Stem Cell Transplantation for Metastatic Solid Tumors
NCT00001880 · National Heart, Lung, and Blood Institute (NHLBI), NIH · Terminated
Key facts
| NCT number | NCT00001880 |
|---|---|
| Title | Stem Cell Transplantation for Metastatic Solid Tumors |
| Official title | Exploratory Study of Non-Myeloablative Allogeneic Stem Cell Transplantation and Donor Lymphocyte Infusions for Metastatic Neoplasms Refractory to Standard Therapy |
| Lead sponsor | National Heart, Lung, and Blood Institute (NHLBI), NIH |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Neoplasm Metastasis |
| Intervention type | Drug |
| Interventions | methotrexate, Cyclosporin |
| Enrollment | 42 |
| Start date | Mar 12, 1999 |
| Primary completion | Aug 14, 2008 |
| Completion | Aug 13, 2020 |
| First posted | Nov 4, 1999 |
| Last update posted | Nov 10, 2021 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: